Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 76-100 of 106 citing articles:

Effectiveness of bivalent mRNA booster vaccines against COVID-19: methodological and public health considerations
Anna Stoliaroff-Pépin, Thomas Harder
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 8, pp. 881-882
Open Access | Times Cited: 2
Applying the Global Leadership Initiative on Malnutrition criteria in patients admitted with SARS‐CoV‐2 infection using computed tomography imaging
Patricia Sheean, P. O'Connor, Cara Joyce, et al.
Nutrition in Clinical Practice (2023) Vol. 38, Iss. 5, pp. 1009-1020
Open Access | Times Cited: 2
Vaccine effectiveness against hospitalisation and comparative odds of hospital admission and severe outcomes with BQ.1, CH.1.1. and XBB.1.5 in England
Freja Kirsebom, Katie Harman, Rachel Lunt, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Modeling the potential public health impact of different vaccination strategies with an omicron-adapted bivalent vaccine in Malaysia
Karan Thakkar, Júlia Spinardi, Moe H. Kyaw, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 714-725
Open Access | Times Cited: 2
Modelling the potential public health impact of different vaccination strategies with an omicron-adapted bivalent vaccine in Thailand
Karan Thakkar, Júlia Spinardi, Moe H. Kyaw, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 860-870
Open Access | Times Cited: 2
Modelling the Potential Public Health Impact of Different COVID-19 Vaccination Strategies with an Adapted Vaccine in Singapore
Karan Thakkar, Júlia Spinardi, Moe H. Kyaw, et al.
Expert Review of Vaccines (2023) Vol. 23, Iss. 1, pp. 16-26
Open Access | Times Cited: 2
Effectiveness of Adapted COVID-19 Vaccines and Ability to Establish Herd Immunity against Omicron BA.1 and BA4-5 Variants of SARS-CoV-2
Pedro Plans-Rubió
Vaccines (2023) Vol. 11, Iss. 12, pp. 1836-1836
Open Access | Times Cited: 2
Design and analysis heterogeneity in observational studies of COVID-19 booster effectiveness: A review and case study
Sabir Meah, Xu Shi, Lars G. Fritsche, et al.
Science Advances (2023) Vol. 9, Iss. 51
Open Access | Times Cited: 2
Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity — IVY Network, 26 Hospitals, October 18, 2023–March 9, 2024
C. Kevin, Diya Surie, Adam S. Lauring, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Modeling the potential public health impact of different vaccination strategies with an adapted vaccine in South Africa
Nadine Al Akoury, Júlia Spinardi, Hammam Haridy, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 750-760
Open Access
Vaccination against COVID-19 in a post-pandemic era
Felippe Lazar Neto, Adrián Ceccato, Otávio T. Ranzani
European Respiratory Society eBooks (2024)
Closed Access
A descriptive review on the real-world impact of Moderna, inc. COVID-19 vaccines
Mary T. Bausch-Jurken, Rachel Dawson, Francesca Ceddia, et al.
Expert Review of Vaccines (2024)
Open Access
Estimating the effect of COVID-19 vaccination and infection variant on post-COVID-19 venous thrombosis or embolism risk
A. G. O'Carroll, Stephanie A Richard, Celia Byrne, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 11
Open Access
Vaccine Research and Development in India for COVID-19 and Influenza
Kawkab Kanjo, Chakshusmathi Ghadiyaram, Raghavan Varadarajan
(2024), pp. 147-173
Closed Access
Effectiveness of mRNA COVID-19 vaccines and hybrid immunity in preventing SARS-CoV-2 infection and symptomatic COVID-19 among adults in the United States
Leora R. Feldstein, Jasmine Ruffin, Ryan E. Wiegand, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Modeling the potential public health and economic impact of different COVID-19 vaccination strategies with an adapted vaccine in the Kingdom of Saudi Arabia
Nadine Al Akoury, Júlia Spinardi, Hammam Haridy, et al.
Expert Review of Vaccines (2024)
Open Access
Post-Pandemic Perspectives: Willingness, Risk Perception and Factors Influencing COVID-19 Booster Vaccine Uptake Among Thai Healthcare Workers and Vulnerable Populations
Amornphat Kitro, Wachiranun Sirikul, Chanachai Polpitakchai, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1381-1381
Open Access
Modeling the Prediction on the Efficacy of a Homologous Third Dose of CoronaVac Against SARS-CoV-2 Omicron BA.1, BA.2, BA.2.12.1, and BA.4/5 — China, 2020–2021
Xinhua Chen, Xufang Bai, Xinghui Chen, et al.
China CDC Weekly (2023) Vol. 5, Iss. 5, pp. 103-107
Open Access | Times Cited: 1
[Review] Early Real World Evidence on the Relative SARS-CoV-2 Vaccine Effectiveness of Bivalent COVID-19 Booster Doses: a Narrative Review
Monica Sañé Schepisi
(2023)
Open Access | Times Cited: 1
The perfect storm: An unseasonably early RSV annual epidemic, a severe annual flu epidemic, and a smoldering COVID-19 pandemic
Sherif B. Mossad
Cleveland Clinic Journal of Medicine (2023) Vol. 90, Iss. 5, pp. 297-306
Open Access | Times Cited: 1
Early Real-World Evidence on the Relative SARS-CoV-2 Vaccine Effectiveness of Bivalent COVID-19 Booster Doses: a Narrative Review
Monica Sañé Schepisi
(2023)
Open Access | Times Cited: 1
No Evidence That Analgesic Use after COVID-19 Vaccination Negatively Impacts Antibody Responses
Bonnie LaFleur, Lisa M. White, Michael D. Dake, et al.
ImmunoHorizons (2023) Vol. 7, Iss. 12, pp. 834-841
Open Access | Times Cited: 1
Multilevel determinants of Covid-19 vaccine hesitancy and undervaccination among marginalized populations in the United States: A scoping review
Peter A. Newman, Thabani Nyoni, Kate Allan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Early real world evidence on the relative SARS-COV-2 vaccine effectiveness of bivalent COVID-19 booster doses: a rapid review
Monica Sañé Schepisi
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Omicron-Specific and Bivalent Omicron-Containing Vaccine Candidates Elicit Potent Virus Neutralisation in the Animal Model
Asghar Abdoli, Hamidreza Jamshidi, Mohammad Taqavian, et al.
Research Square (Research Square) (2023)
Open Access

Scroll to top